ASCLS eNewsBytes

• Combating antimicrobial resistance globally requires maintaining safety of available antibiotics and a robust pipeline; animal and environmental health strategies also needed October 26, 2021
  Combating antimicrobial resistance — which kills about 36,000 people a year in the United States alone — not only requires a strong pipeline of new antimicrobial medicines and other products, but also preserving the effectiveness of those already in use, says a new congressionally mandated report from the National Academies of Sciences, Engineering and Medicine. […]
• New cancer treatment may reawaken the immune system October 26, 2021
  Researchers have discovered a new way to jump-start the immune system to attack tumors, which could allow cancer immunotherapy to be used against more types of cancer.
• Interferon treatment coupled with bone marrow transplant reduces risk of leukemia recurrence October 26, 2021
  Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
• No risk of pregnancy loss from COVID-19 vaccination: Study October 26, 2021
  A new study published in The New England Journal of Medicine has found no correlation between COVID-19 vaccinations and risk of first-trimester miscarriages, providing further evidence of the safety of COVID-19 vaccination during pregnancy.
• What is the ideal duration of daptomycin and ceftaroline combination therapy for MRSA bacteremia? October 26, 2021
  Staphylococcus aureus is the leading cause of bloodstream infections worldwide, associated with a high incidence of metastatic infections such as infective endocarditis and osteomyelitis. The Infectious Diseases Society of America clinical guidelines for the management of MRSA infections endorse the use of vancomycin or daptomycin as standard therapy for MRSA bacteremia.